Medreich Limited
Medreich Limited is a Public Non-govt company company incorporated in 1973 and based in Karnataka, India. Medreich Limited operates in Allopathic pharmaceutical preparations, manufacturing (NIC 24232) with authorized capital of ₹160.50 Cr and paid-up capital of ₹40.16 Cr. For 2023-24, the company reported revenue of ₹1502.85 Cr and profit after tax of ₹204.89 Cr. The board has 3 active directors. RegisterKaro's provisional Compliance Health Score for the company is 100/100 (grade A), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
3 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 26 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +9d | filed |
| MGT-7 | FY2022-23 | 23 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Medreich Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 944929889 | Kotak Mahindra Bank Ltd(Bank) | ₹8.41 Cr | 12 Mar 2021 | Open |
| 953957977 | Kotak Mahindra Bank Ltd(Bank) | ₹6.57 Cr | 12 Mar 2023 | Satisfied |
| 824134099 | ICICI Bank Ltd(Bank) | ₹24.05 Cr | 12 Mar 2020 | Open |
| 113119734 | State Bank of India(Bank) | ₹14.60 Cr | 27 Jan 2020 | Satisfied |
| 725318840 | State Bank of India(Bank) | ₹11.40 Cr | 19 Sep 2020 | Satisfied |
| 595049571 | Axis Bank Ltd(Bank) | ₹2.51 Cr | 27 Jan 2019 | Open |
Charge IDs, lenders & amounts for Medreich Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2017-18 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2021-22 | 2020-21 | 2019-20 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +87.0% | +24.0% | — | |
| Profit after Tax2023-24 | +53.0% | +58.0% | — | |
| Net Worth2023-24 | +36.0% | +57.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2017-18 | +6.19% | — | +9.20% | +3.64% | 1.52 | |||
| 2019-20 | +4.07% | +26.05% | +6.56% | +2.79% | 1.36 | |||
| 2020-21 | +10.62% | +16.25% | +16.60% | +8.02% | 1.07 | |||
| 2021-22 | +10.04% | +3.12% | +13.92% | +7.71% | 0.80 | |||
| 2023-24 | +13.63% | +22.92% | +16.56% | +11.68% | 0.42 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 2,69,01,992 | 58.86% |
| Institutional Investors | 3 | 53,28,429 | 11.66% |
| Public & Others | 48 | 1,34,71,349 | 29.48% |
Promoter, institutional & public holding for Medreich Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
349 peersEvents & timeline
4External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.